These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 1513103

  • 1. Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion.
    Flyvbjerg A, Marshall SM, Frystyk J, Hansen KW, Harris AG, Orskov H.
    Kidney Int; 1992 Apr; 41(4):805-12. PubMed ID: 1513103
    [Abstract] [Full Text] [Related]

  • 2. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
    Grønbaek H, Nielsen B, Osterby R, Harris A, Orskov H, Flyvbjerg A.
    Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170
    [Abstract] [Full Text] [Related]

  • 3. Effect of a somatostatin analogue (SMS 201-995) on renal function and urinary protein excretion in diabetic rats.
    Igarashi K, Nakazawa A, Tani N, Yamazaki M, Ito S, Shibata A.
    J Diabet Complications; 1991 Feb; 5(2-3):181-3. PubMed ID: 1770039
    [Abstract] [Full Text] [Related]

  • 4. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
    Raz I, Rubinger D, Popovtzer M, Grønbaek H, Weiss O, Flyvbjerg A.
    Diabetes; 1998 Jun; 47(6):924-30. PubMed ID: 9604870
    [Abstract] [Full Text] [Related]

  • 5. [Octreotide suppresses the kidney weight and glomerular hypertrophy in diabetic rats].
    Iwasaki S.
    Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):247-55. PubMed ID: 8501854
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice.
    Flyvbjerg A, Bennett WF, Rasch R, Kopchick JJ, Scarlett JA.
    Diabetes; 1999 Feb; 48(2):377-82. PubMed ID: 10334317
    [Abstract] [Full Text] [Related]

  • 7. Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes.
    Grønbaek H, Vogel I, Osterby R, Lancranjan I, Flyvbjerg A, Orskov H.
    Kidney Int; 1998 Jan; 53(1):173-80. PubMed ID: 9453015
    [Abstract] [Full Text] [Related]

  • 8. Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention.
    Grønbaek H, Nielsen B, Frystyk J, Orskov H, Flyvbjerg A.
    J Endocrinol; 1995 Oct; 147(1):95-102. PubMed ID: 7490542
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice.
    Grønbaek H, Nielsen B, Schrijvers B, Vogel I, Rasch R, Flyvbjerg A.
    J Endocrinol; 2002 Mar; 172(3):637-43. PubMed ID: 11874712
    [Abstract] [Full Text] [Related]

  • 10. Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats.
    Grønbaek H, Volmers P, Bjørn SF, Osterby R, Orskov H, Flyvbjerg A.
    Am J Physiol; 1997 May; 272(5 Pt 1):E918-24. PubMed ID: 9176194
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats.
    Flyvbjerg A, Jørgensen KD, Marshall SM, Orskov H.
    Am J Physiol; 1991 Apr; 260(4 Pt 1):E568-74. PubMed ID: 2018120
    [Abstract] [Full Text] [Related]

  • 12. Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats.
    Flyvbjerg A, Frystyk J, Thorlacius-Ussing O, Orskov H.
    Diabetologia; 1989 Apr; 32(4):261-5. PubMed ID: 2759363
    [Abstract] [Full Text] [Related]

  • 13. Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats.
    Flyvbjerg A, Bornfeldt KE, Marshall SM, Arnqvist HJ, Orskov H.
    Diabetologia; 1990 Jun; 33(6):334-8. PubMed ID: 2199279
    [Abstract] [Full Text] [Related]

  • 14. The calcium channel blocker nitrendipine attenuates renal and glomerular hypertrophy in diabetic rats.
    Nielsen B, Gronbaek H, Osterby R, Orskov H, Flyvbjerg A.
    Exp Nephrol; 1999 Jun; 7(3):242-50. PubMed ID: 10352365
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of growth hormone, insulin-like growth factors (IGFs), and IGF-binding proteins in experimental diabetic kidney disease.
    Flyvbjerg A, Landau D, Domene H, Hernandez L, Grønbaek H, LeRoith D.
    Metabolism; 1995 Oct; 44(10 Suppl 4):67-71. PubMed ID: 7476314
    [Abstract] [Full Text] [Related]

  • 18. An inhibition of urinary albumin excretion by protease inhibitor in streptozotocin-diabetic rats.
    Ikeda T, Hoshino T.
    Nephron; 1996 Oct; 74(4):709-12. PubMed ID: 8956306
    [Abstract] [Full Text] [Related]

  • 19. Octreotide administration in diabetic rats: effects on renal function and morphology.
    Usenmez T, Yildiz O, Oktenli C, Ozgurtas T, Kutlu M.
    J Diabetes Complications; 2000 Oct; 14(1):53-9. PubMed ID: 10925067
    [Abstract] [Full Text] [Related]

  • 20. Additive increase in kidney insulin-like growth factor I and initial renal enlargement in uninephrectomized-diabetic rats.
    Flyvbjerg A, Frystyk J, Marshall SM.
    Horm Metab Res; 1990 Oct; 22(10):516-20. PubMed ID: 2079313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.